Abstract:first_page Download PDF settings Order Article Reprints Font Type: Arial Georgia Verdana Font Size: Aa Aa Aa Line Spacing:    Column Width:    Background: Open Access Editorial Current Research for Heart Disease Biology and Therapeutics by Claudia Kusmic Claudia Kusmic SciProfiles Scilit Preprints.org Google Scholar Institute of Clinical Physiology, National Research Council (CNR), 56124 Pisa, Italy Int. J. Mol. Sci. 2024 , 25 (19), 10744; https://doi.org/10.3390/ijms251910744 (registering DOI) Submission received: 3 October 2024 / Accepted: 5 October 2024 / Published: 6 October 2024 (This article belongs to the Special Issue Current Research for Heart Disease Biology and Therapeutics) Download keyboard_arrow_down Download PDF Download XML Versions Notes Cardiac and vascular diseases are the leading cause of death globally. Heart disease covers a wide range of structural and functional changes that affect the heart, including conditions like coronary artery disease, abnormal heart rhythms, congenital heart defects, valve disease, and heart failure (HF). In many cases, less severe forms of heart disease have the potential to advance or intersect with other conditions, possibly leading to a more significant pathological outcome, including severe HF. Heart failure is a significant public health challenge due to its high prevalence and severe impact on patients and healthcare systems. It affects about 2% of the global population and is expected to increase due to ageing populations and improved survival rates from other cardiac conditions. By 2030, it is projected that nearly 50% of the population over 60 years of age will be affected by HF [1,2]. Cardiac research has increasingly focused on exploring new and innovative approaches to better understand the biological basis of cardiac disease onset and progression, as well as to develop novel therapeutic approaches that target molecular pathways involved in the transition to pathophysiological conditions.This Special Issue of the International Journal of Molecular Science features four research articles and six reviews that cover various aspects of cardiac pathophysiology. These contributions include studies of basic research and therapeutic and functional approaches. They also provide new insights into potential molecular targets for therapeutic strategies and new diagnostic and prognostic markers in heart disease.Two reviews specifically address different aspects of acute myocardial infarction (MI). In particular, Salvadori and colleagues thoroughly analyse and critically discuss the latest research on epigenetic changes following myocardial infarction (MI). They specifically examine the role of miRNAs and their interaction with important signalling pathways in the different early stages of the healing process after an ischemic event, namely the inflammation, resolution, and maturation phases [3]. Additionally, they shed light on the differences in the risk factors and long-term outcomes for MI between males and females.Zheng et al. revisit the role of vitamin C, a well-established antioxidant that reduces oxidative stress [4]. The beneficial role of vitamin C in the cardiovascular system remains controversial, and previous studies on the association between vitamin C levels and MI have shown conflicting results. Although vitamin C demonstrates a strong antioxidant function at both the cell -Abstract Truncated-

The Emerging Field of Cardioimmunology: Past, Present and Foreseeable Future

Intersection of Immunology and Metabolism in Myocardial Disease

The Role of Immunogenicity in Cardiovascular Disease.

Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives

Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation

Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?

Present Researching Approaches and Future Prospects forTreatment of Cardiac Diseases - Integrative Medicine

Heart brain axis in health and disease: role of innate and adaptive immunity

Revisiting Cardiac Biology in the Era of Single Cell and Spatial Omics

New Approaches to Target Inflammation in Heart Failure: Harnessing Insights from Studies of Immune Cell Diversity

Emerging Roles for Dendritic Cells in Heart Failure

The inflammatory spectrum of cardiomyopathies

Current Research for Heart Disease Biology and Therapeutics

The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets

Myocardial Inflammation in Heart Failure With Reduced and Preserved Ejection Fraction

From Psychostasis to the Discovery of Cardiac Nerves: The Origins of the Modern Cardiac Neuromodulation Concept

Neurocardiology: translational advancements and potential

Cardiomyocyte electrophysiology and its modulation: current views and future prospects

The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy